1 SEC 13D/G filing tracked · Last updated Aug 27, 2026
$PPCB Propanc Biopharma Announces Compelling New Preclinical Pancreatic Cancer Data for PRP Showing >90% Tumor Growth Inhibition and >2.5-Fold Surviva…